Randomized, Phase II Study of the Insulin-Like Growth Factor-1 Receptor Inhibitor IMC-A12, With or Without Cetuximab, in Patients With Cetuximab- or Panitumumab-Refractory Metastatic Colorectal CancerDiane Reidy‐Lagunes, Leonard B. Saltz|Journal of Clinical Oncology|2010Cited by 139
RETRACTED: Circulating tumor DNA status to direct adjuvant immunotherapy for mismatch repair deficient tumorsYelena Y. Janjigian, Luis A. Díaz, Michael B. Foote et al.|Research Square|2025Cited by 0